Development-stage biopharmaceutical company that acquires promising therapeutic small molecules and develops them through proof of concept in humans for subsequent sale or out-licensing to larger pharmaceutical companies.
Cereplast, Inc. (OTCQB:CERP) designs and manufactures proprietary bioplastics, which are used as substitutes for traditional plastics in all major converting processes such as injection molding, thermoforming, blow molding and extrusions.
Trend follower, portfolio manager, market technician. Former sales trader to hedge funds/institutions, research analyst, prop trader, buy-side head of desk. Only took 25 years to find what works for me. Always learning.